We are live on
!
Find out more
MCM
Marsico Capital Management Portfolio holdings
AUM
$3.4B
1-Year Est. Return
51.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+51.58%
3 Year Est. Return
+243.93%
5 Year Est. Return
+321.58%
10 Year Est. Return
+1,831.46%
AUM
$11.3B
AUM Growth
-$536M
(-4.5%)
Cap. Flow
-$722M
Cap. Flow
% of AUM
-6.38%
Top 10 Holdings %
Top 10 Hldgs %
44.21%
Holding
104
New
17
Increased
29
Reduced
44
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$232M |
| 2 |
Electronic Arts
EA
|
+$162M |
| 3 |
Salesforce
CRM
|
+$118M |
| 4 |
Bausch Health
BHC
|
+$90.4M |
| 5 |
Zoetis
ZTS
|
+$87.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$265M |
| 2 |
Biogen
BIIB
|
+$215M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$190M |
| 4 |
Union Pacific
UNP
|
+$158M |
| 5 |
Alibaba
BABA
|
+$148M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.72% |
| 2 | Communication Services | 19.78% |
| 3 | Technology | 14.98% |
| 4 | Consumer Discretionary | 12.37% |
| 5 | Financials | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
CVS Health
CVS
$134B
| $162M | 1.43% |
1,539,860
-175,557
| -10% | -$17.9M |
|
27
Pacira BioSciences
PCRX
$1.06B
| $161M | 1.42% |
2,277,980
+331,788
| +17% | +$26.1M |
|
28
NXP Semiconductors
NXPI
$56.5B
| $160M | 1.41% |
1,629,865
-57,559
| -3% | -$5.9M |
|
29
Corpay
CPAY
$25.2B
| $142M | 1.26% |
911,476
+9,811
| +1% | +$1.54M |
|
30
Delta Air Lines
DAL
$60.2B
| $97.7M | 0.86% |
2,379,158
-383,761
| -14% | -$16.8M |
|
31
Tesla
TSLA
$1.27T
| $93.9M | 0.83% |
5,248,605
-1,240,410
| -19% | -$19.6M |
|
|
32
Zoetis
ZTS
$32.3B
| $88.2M | 0.78% |
+1,828,140
| New | +$87.3M |
|
33
Constellation Brands
STZ
$22.4B
| $86.8M | 0.77% |
748,169
-107,534
| -13% | -$12.7M |
|
|
34
Union Pacific
UNP
$173B
| $81.8M | 0.72% |
857,830
-1,515,304
| -64% | -$158M |
|
35
Palo Alto Networks
PANW
$283B
| $78M | 0.69% |
2,679,372
+2,059,206
| +332% | +$55M |
|
36
Norwegian Cruise Line
NCLH
$9.07B
| $65.5M | 0.58% |
1,168,959
-241,391
| -17% | -$13M |
|
37
Mastercard
MA
$500B
| $60.4M | 0.53% |
645,965
-12,265
| -2% | -$1.13M |
|
38
lululemon athletica
LULU
$14B
| $59.7M | 0.53% |
914,298
+343,105
| +60% | +$22.3M |
|
39
Liberty Global Class C
LBTYK
$3.63B
| $59M | 0.52% |
1,440,252
-602,478
| -29% | -$25M |
|
|
ENDP
40
DELISTED
Endo International plc
ENDP
| $54.4M | 0.48% |
682,390
+12,051
| +2% | +$1.04M |
|
41
Signet Jewelers
SIG
$3.69B
| $51M | 0.45% |
397,842
+386,563
| +3,427% | +$51.8M |
|
42
Incyte
INCY
$24B
| $50.6M | 0.45% |
485,980
+214,253
| +79% | +$22.2M |
|
43
Royal Caribbean
RCL
$86.7B
| $50M | 0.44% |
635,396
-9,069
| -1% | -$691K |
|
44
Booking.com
BKNG
$149B
| $48.2M | 0.43% |
+1,045,625
| New | +$49.9M |
|
|
EVHC
45
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $47.6M | 0.42% |
402,583
-160,660
| -29% | -$18.3M |
|
46
Chipotle Mexican Grill
CMG
$47.5B
| $47.2M | 0.42% |
3,898,350
+2,298,500
| +144% | +$29.1M |
|
|
TWX
47
DELISTED
Time Warner Inc
TWX
| $41.7M | 0.37% |
477,443
+42,629
| +10% | +$3.64M |
|
48
Aptiv
APTV
$12.1B
| $41.2M | 0.36% |
+484,084
| New | +$41.4M |
|
49
Alkermes
ALKS
$8.31B
| $37.2M | 0.33% |
578,279
-46,986
| -8% | -$2.88M |
|
50
Lowe's Companies
LOW
$119B
| $35.6M | 0.31% |
531,576
-22,219
| -4% | -$1.58M |
|
Similar funds
BG
OAM
DFO
VFCM
CIA
EFM
JGC
PWP
Marsico Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Marsico Capital Management held 104 positions worth $11.3B, down 4.5% from $11.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Marsico Capital Management withdrew a net $722M in Q2 2015, closing 13 positions and reducing 44 holdings. Its most notable exit was Gilead Sciences, an estimated $265M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 30% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Marsico Capital Management opened a new position in Zoetis worth $88.2M.
- Marsico Capital Management's largest Q2 2015 buy was Zoetis: 1,828,140 shares worth $88.2M.
- Marsico Capital Management added most to Illumina in Q2 2015, an estimated $232M increase.
- Marsico Capital Management's biggest Q2 2015 reduction was Biogen, cutting an estimated $215M.
- Marsico Capital Management fully exited Gilead Sciences in Q2 2015, selling an estimated $265M.
- Marsico Capital Management's ten largest holdings make up 44% of its $11.3B portfolio in Q2 2015.
- Marsico Capital Management opened 17 new positions and closed 13 in Q2 2015.
- Marsico Capital Management's portfolio value fell 4.5% quarter-over-quarter to $11.3B.
Based on Marsico Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.